Recombinant Human Erythropoietin (rhEPO) as an Adjuvant for Autologous Blood Transfusion

By Metzger U.   Honegger H.P.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 956-957

Elsevier

Access to resources Recommend Favorite

Recombinant human erythropoietin attenuates weight loss in a murine cancer cachexia model

By Halteren H.   Bongaerts G.   Verhagen C.   Kamm Y.   Willems J.   Grutters G.   Koopman J.   Wagener D.  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 4, 2004-04 ,pp. : 211-216

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Recombinant Human Erythropoietin on the Antitumor Effect of Cisplatin in SCID Mice Bearing Human Ovarian Cancer: A Possible Oxygen Effect

By Silver D.F.   Piver M.S.  

Gynecologic Oncology, Vol. 73, Iss. 2, 1999-05 ,pp. : 280-284

Elsevier

Access to resources Recommend Favorite

Management of chemotherapy-related anaemia with low-dose recombinant human erythropoietin in patients with small cell lung cancer

By Zarogoulidis K.   Papagiannis A.   Ziogas E.   Fahantidou E.   Dermitzakis G.   Gioulekas D.   Vamvalis C.  

European Journal of Cancer, Vol. 33, Iss. 14, 1997-12 ,pp. : 2428-2431

Elsevier

Access to resources Recommend Favorite

Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA

By Barrou Benoît   Benoît Gérard   Ouldkaci Mahmoud   Cussenot Olivier   Salcedo Margarita   Agrawal Sudhanshu   Massicard Séverine   Bercovici Nadège   Ericson Mats   Thiounn Nicolas  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 5, 2004-05 ,pp. : 453-460

Springer Publishing Company

Access to resources Recommend Favorite